Oridonin inhibits growth and induces apoptosis of human neurocytoma cells via the Wnt/β‑catenin pathway

Liang,Jingyan; Wang,Weiguang; Wei,Lifu; Gao,Shan; Wang,Yingge

doi:10.3892/ol.2018.8977

Oridonin inhibits growth and induces apoptosis of human neurocytoma cells via the Wnt/β‑catenin pathway

Authors:
- Jingyan Liang
- Weiguang Wang
- Lifu Wei
- Shan Gao
- Yingge Wang
View Affiliations

Affiliations: Department of Anatomy, College of Medicine, Yangzhou University, Yangzhou, Jiangsu 225009, P.R. China, Department of Hematology, First Affiliated Hospital of Jiamusi University, Jiamusi, Heilongjiang 154003, P.R. China, Department of Neurology, Affiliated Hospital of Yangzhou University, Yangzhou, Jiangsu 225001, P.R. China, Department of Neurology, Shanghai JiaoTong University Affiliated Sixth People Hospital, South Campus, Shanghai 200233, P.R. China, The Research Center for Vascular Biology, College of Medicine. Yangzhou University, Yangzhou, Jiangsu 225009, P.R. China
Published online on: June 18, 2018 https://doi.org/10.3892/ol.2018.8977
Pages: 3333-3340

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Central neurocytoma (CN) is a rare periventricular tumor of the central nervous system in young adults. Typically, patients with CN exhibit a favorable prognosis, but in certain cases the clinical course is more aggressive. Therefore, investigating effective therapeutic approaches is important. Oridonin has attracted attention due to its antitumor activities. However, the role of oridonin in tumorigenesis and progression remains unknown. The present study examined the antitumor function of oridonin in CN cells, and investigated the underlying molecular mechanism. An MTT assay suggested that treatment with oridonin was able to significantly inhibit the proliferation of CN cells. The annexin V‑fluorescein isothiocyanate/propidium iodide assay and western blot analysis demonstrated that oridonin was able to induce apoptosis and alter the expression of apoptosis‑associated proteins by downregulating anti‑apoptotic protein, B‑cell lymphoma‑2 (Bcl‑2), and upregulating pro‑apoptosis proteins, Bcl‑2‑like protein 4, cleaved caspase‑3 and cleaved poly(ADP‑ribose) polymerase 1. Subsequently, the Wnt/β‑catenin signaling pathway was examined. Western blot analysis indicated that oridonin markedly decreased the expression of β‑catenin, cyclin D1 and v‑myc avian myelocytomatosis viral oncogene homolog. Furthermore, β‑catenin was silenced by small interference RNA or overexpressed in CN cells, and the effect on cell proliferation was examined. The results indicated that silencing of β‑catenin enhanced the inhibitory effect of oridonin on cell growth, whereas the overexpression of β‑catenin attenuated this effect. These data indicated that oridonin inhibited proliferation and induced apoptosis to exert its antitumor activity in CN cells by repressing Wnt/β‑catenin signaling. Therefore, the present study suggested that oridonin might be an effective adjuvant agent, and that the Wnt/β‑catenin signaling pathway may be a potent target for the therapy in CN.

View Figures

View References

1	Kim DG, Paek SH, Kim IH, Chi JG, Jung HW, Han DH, Choi KS and Cho BK: Central neurocytoma: The role of radiation therapy and long term outcome. Cancer. 79:1995–2002. 1997. View Article : Google Scholar : PubMed/NCBI
2	Schild SE, Scheithauer BW, Haddock MG, Schiff D, Burger PC, Wong WW and Lyons MK: Central neurocytomas. Cancer. 79:790–795. 1997. View Article : Google Scholar : PubMed/NCBI
3	Schmidt MH, Gottfried ON, von Koch CS, Chang SM and McDermott MW: Central neurocytoma: A review. J Neurooncol. 66:377–384. 2004. View Article : Google Scholar : PubMed/NCBI
4	Kuo LM, Kuo CY, Lin CY, Hung MF, Shen JJ and Hwang TL: Intracellular glutathione depletion by oridonin leads to apoptosis in hepatic stellate cells. Molecules. 19:3327–3344. 2014. View Article : Google Scholar : PubMed/NCBI
5	Kadota S, Basnet P, Ishii E, Tamura T and Namba T: Antibacterial activity of trichorabdal A from Rabdosia trichocarpa against Helicobacter pylori. Zentralblatt fur Bakteriologie: Int J Med Microbiol. 286:63–67. 1997. View Article : Google Scholar
6	Yang J, Jiang H, Wang C, Yang B, Zhao L, Hu D, Qiu G, Dong X and Xiao B: Oridonin triggers apoptosis in colorectal carcinoma cells and suppression of microRNA-32 expression augments oridonin-mediated apoptotic effects. Biomed Pharmacother. 72:125–134. 2015. View Article : Google Scholar : PubMed/NCBI
7	Wang H, Wang YF, Liu TG, Xiang XL and Huang SL: Experimental study on anti-pancreatic cancer effect of oridonin. Zhong Yao Cai. 37:1230–1233. 2014.(In Chinese). PubMed/NCBI
8	Li Y, Wang Y, Wang S, Gao Y, Zhang X and Lu C: Oridonin phosphate-induced autophagy effectively enhances cell apoptosis of human breast cancer cells. Med Oncol. 32:3652015. View Article : Google Scholar : PubMed/NCBI
9	Wang YY, Lv YF, Lu L and Cai L: Oridonin inhibits mTOR signaling and the growth of lung cancer tumors. Anticancer Drugs. 25:1192–1200. 2014. View Article : Google Scholar : PubMed/NCBI
10	Bohanon FJ, Wang X, Ding C, Ding Y, Radhakrishnan GL, Rastellini C, Zhou J and Radhakrishnan RS: Oridonin inhibits hepatic stellate cell proliferation and fibrogenesis. J Surg Res. 190:55–63. 2014. View Article : Google Scholar : PubMed/NCBI
11	Bu HQ, Liu DL, Wei WT, Chen L, Huang H, Li Y and Cui JH: Oridonin induces apoptosis in SW1990 pancreatic cancer cells via p53- and caspase-dependent induction of p38 MAPK. Oncol Rep. 31:975–982. 2014. View Article : Google Scholar : PubMed/NCBI
12	Zhang CL, Wu LJ, Tashiro S, Onodera S and Ikejima T: Oridonin induces a caspase-independent but mitochondria- and MAPKdependent cell death in the murine fibrosarcoma cell line L929. Biol Pharm Bull. 27:1527–1531. 2004. View Article : Google Scholar : PubMed/NCBI
13	Behrens J and Lustig B: The Wnt connection to tumorigenesis. Int J Dev Biol. 48:477–487. 2004. View Article : Google Scholar : PubMed/NCBI
14	Knoepfler PS, Cheng PF and Eisenman RN: N-myc is essential during neurogenesis for the rapid expansion of progenitor cell populations and the inhibition of neuronal differentiation. Genes Dev. 16:2699–2712. 2002. View Article : Google Scholar : PubMed/NCBI
15	Sim FJ, Keyoung HM, Goldman JE, Kim DK, Jung HW, Roy NS and Goldman SA: Neurocytoma is a tumor of adult neuronal progenitor cells. J Neurosci. 26:12544–12555. 2006. View Article : Google Scholar : PubMed/NCBI
16	Liu Y, Liu YZ, Zhang RX, Wang X, Meng ZJ, Huang J, Wu K, Luo JY, Zuo GW, Chen L, et al: Oridonin inhibits the proliferation of human osteosarcoma cells by suppressing Wnt/β-catenin signaling. Int J Oncol. 45:795–803. 2014. View Article : Google Scholar : PubMed/NCBI
17	Roy NS, Benraiss A, Wang S, Fraser RA, Goodman R, Couldwell WT, Nedergaard M, Kawaguchi A, Okano H and Goldman SA: Promoter-targeted selection and isolation of neural progenitor cells from the adult human ventricular zone. J Neurosci Res. 59:321–331. 2000. View Article : Google Scholar : PubMed/NCBI
18	Roy NS, Wang S, Jiang L, Kang J, Benraiss A, Harrison-Restelli C, Fraser RA, Couldwell WT, Kawaguchi A, Okano H, et al: In vitro neurogenesis by progenitor cells isolated from the adult human hippocampus. Nat Med. 6:271–277. 2000. View Article : Google Scholar : PubMed/NCBI
19	Lee SJ, Kim JE, Paek SH, Keyoung HM, Kim DG and Jung HW: Primary cell culture of central neurocytomas. J Korean Neurosurg Soc. 34:238–244. 2003.
20	Wu K, Yang Q, Mu Y, Zhou L, Liu Y, Zhou Q and He B: Berberine inhibits the proliferation of colon cancer cells by inactivating Wnt/beta-catenin signaling. Int J Oncol. 41:292–298. 2012.PubMed/NCBI
21	He TC, Zhou S, da Costa LT, Yu J, Kinzler KW and Vogelstein B: A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci USA. 95:2509–2514. 1998. View Article : Google Scholar : PubMed/NCBI
22	Tang N, Song WX, Luo J, Luo X, Chen J, Sharff KA, Bi Y, He BC, Huang JY, Zhu GH, et al: BMP-9-induced osteogenic differentiation of mesenchymal progenitors requires functional canonical Wnt/beta-catenin signalling. J Cell Mol Med. 13:2448–2464. 2009. View Article : Google Scholar : PubMed/NCBI
23	Livak KJ and Schmittgen TD: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-delta delta C(t)) method. Methods. 25:402–408. 2001. View Article : Google Scholar : PubMed/NCBI
24	Feng M, Li J, Wang J, Ma C, Jiao Y, Wang Y, Zhang J, Sun Q, Ju Y, Gao L1 and Zhao Y: High glucose increases LPS-induced DC apoptosis through modulation of ERK1/2, AKT and Bax/Bcl-2. BMC Gastroenterol. 14:982014. View Article : Google Scholar : PubMed/NCBI
25	Abelson PH: Medicine from plants. Science. 247:5131990. View Article : Google Scholar : PubMed/NCBI
26	Liu H, Qian C and Shen Z: Anti-tumor activity of oridonin on SNU-5 subcutaneous xenograft model via regulation of c-Met pathway. Tumour Biol. 35:9139–9146. 2014. View Article : Google Scholar : PubMed/NCBI
27	Liu YQ, Mu ZQ, You S, Tashiro S, Onodera S and Ikejima T: Fas/FasL signaling allows extracelluar-signal regulated kinase to regulate cytochrome c release in oridonin-induced apoptotic U937 cells. Biol Pharm Bull. 29:1873–1879. 2006. View Article : Google Scholar : PubMed/NCBI
28	Jin S, Shen JN, Wang J, Huang G and Zhou JG: Oridonin induced apoptosis through Akt and MAPKs signaling pathways in human osteosarcoma cells. Cancer Biol Ther. 6:261–268. 2007. View Article : Google Scholar : PubMed/NCBI
29	Cheng Y, Qiu F, Ye YC, Tashiro S, Onodera S and Ikejima T: Oridonin induces G2/M arrest and apoptosis via activating ERK-p53 apoptotic pathway and inhibiting PTK-Ras-Raf-JNK survival pathway in murine fibrosarcoma L929 cells. Arch Biochem Biophys. 490:70–75. 2009. View Article : Google Scholar : PubMed/NCBI
30	Stennicke HR and Salvesen GS: Caspases-controlling intracellular signals by protease zymogen activation. Biochim Biophys Acta. 1477:299–306. 2000. View Article : Google Scholar : PubMed/NCBI
31	Gray DC, Mahrus S and Wells JA: Activation of specific apoptotic caspases with an engineered small molecule-activated protease. Cell. 142:637–646. 2010. View Article : Google Scholar : PubMed/NCBI
32	Clevers H: Wnt/beta-catenin signaling in development and disease. Cell. 127:469–480. 2006. View Article : Google Scholar : PubMed/NCBI
33	Wharton KA Jr: Runnin' with the Dvl: Proteins that associate with Dsh/Dvl and their significance to Wnt signal transduction. Dev Biol. 253:1–17. 2003. View Article : Google Scholar : PubMed/NCBI
34	Rao TP and Kühl M: An updated overview on Wnt signaling pathways: A prelude for more. Circ Res. 106:1798–1806. 2010. View Article : Google Scholar : PubMed/NCBI
35	Minde DP, Anvarian Z, Rüdiger SG and Maurice MM: Messing up disorder: How do missense mutations in the tumor suppressor protein APC lead to cancer? Mol Cancer. 10:1012011. View Article : Google Scholar : PubMed/NCBI
36	Minde DP, Radli M, Forneris F, Maurice MM and Stefan Rüdiger GD: large extent of disorder in adenomatous polyposis coli offers a strategy to guard Wnt signalling against point mutations. PLoS One. 8:e772572013. View Article : Google Scholar : PubMed/NCBI
37	MacDonald BT, Tamai K and He X: Wnt/beta-catenin signaling: Components, mechanisms, and diseases. Dev Cell. 17:9–26. 2009. View Article : Google Scholar : PubMed/NCBI
38	Lopez J and Tait SW: Mitochondrial apoptosis: Killing cancer using the enemy within. Br J Cancer. 112:957–962. 2015. View Article : Google Scholar : PubMed/NCBI
39	Cohen GM: Caspases: The executioners of apoptosis. Biochem J. 326:1–16. 1997. View Article : Google Scholar : PubMed/NCBI
40	Tetsu O and McCormick F: Beta-catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature. 398:422–426. 1999. View Article : Google Scholar : PubMed/NCBI
41	Reya T and Clevers H: Wnt signalling in stem cells and cancer. Nature. 434:843–850. 2005. View Article : Google Scholar : PubMed/NCBI
42	Damalas A, Ben-Ze'ev A, Simcha I, Shtutman M, Leal JF, Zhurinsky J, Geiger B and Oren M: Excess beta-catenin promotes accumulation of transcriptionally active p53. EMBO J. 18:3054–3063. 1999. View Article : Google Scholar : PubMed/NCBI
43	He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B and Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science. 281:1509–1512. 1998. View Article : Google Scholar : PubMed/NCBI
44	Klaus A and Birchmeier W: Wnt signalling and its impact on development and cancer. Nat Rev Cancer. 8:387–398. 2008. View Article : Google Scholar : PubMed/NCBI
45	Li CY, Wang EQ, Cheng Y and Bao JK: Oridonin: An active diterpenoid targeting cell cycle arrest, apoptotic and autophagic pathways for cancer therapeutics. Int J Biochem Cell Biol. 43:701–704. 2011. View Article : Google Scholar : PubMed/NCBI
46	Li X, Li X, Wang J, Ye Z and Li JC: Oridonin up-regulates expression of P21 and induces autophagy and apoptosis in human prostate cancer cells. Int J Biol Sci. 8:901–912. 2012. View Article : Google Scholar : PubMed/NCBI
47	Hu HZ, Yang YB and Xu XD: Oridonin induces apoptosis via PI3K/Akt pathway in cervical carcinoma HeLa cell line. Acta Pharmacol Sin. 28:1819–1826. 2007. View Article : Google Scholar : PubMed/NCBI